Skip to main content

Find Clinical Trials

Home
Conditions
Uveal Melanoma

Clinical trial condition

Uveal Melanoma

Explore clinical trials studying Uveal Melanoma. Study availability and eligibility vary by location and protocol.

201 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Uveal Melanoma trial results

Completed

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

NCT01961115

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +25 more
Locations: Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Duke University Medical Center Durham, North Carolina, United States

Cleveland Clinic Foundation Cleveland, Ohio, United States

University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Completed

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT00450255

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +22 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma

NCT01893099

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations: Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland

View Trial Details

Completed

Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

NCT01034787

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma

NCT01252251

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

NCT01143402

Conditions: Eye Diseases, Eye Neoplasms, Iris Melanoma, +17 more
Locations: University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States

Mount Sinai Medical Center Miami Beach, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

View all 33 locations

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT00471471

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +17 more
Locations: UPMC Cancer Centers Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma

NCT00680225

Conditions: Choroidal Melanoma, Eye Diseases, Eye Neoplasms, +12 more
Locations: New England Retina Associates Hamden, Connecticut, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

NCT00398073

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)

NCT01974752

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +16 more
Locations: Research Site Los Angeles, California, United States

Research Site Aurora, Colorado, United States

Research Site Atlanta, Georgia, United States

Research Site Lutherville, Maryland, United States

View all 31 locations

View Trial Details